Abionic is a Swiss-based start-up, strongly positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology in Lausanne, Switzerland), Abionic uses the most advanced technology to offer the medical sector a novel point-of-care diagnostic tool that provides user-friendly allergy diagnoses promoting personalized medication.